According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โฌ58.05 Million. In 2026 the company made a revenue of โฌ58.05 Million an increase over the revenue in the year 2025 that were of โฌ55.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.